Company: INSP
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001609550-25-000020
Chunk: 16

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 1
Chunk 16
---
— — — Share repurchase of common stock(442,649)(1)(75,008)— — (75,009)Other comprehensive loss— — — (309)— (309)Net income— — — — 2,992 2,992 Balance at March 31, 202529,467,300 $29 $924,409 $227 $(288,922)$635,743 

Three Months Ended March 31, 2024Common StockSharesAmountAdditionalPaid-InCapitalAccumulatedOtherComprehensiveIncome (Loss)AccumulatedDeficitTotalStockholders'EquityBalance at December 31, 202329,560,464 $30 $917,107 $800 $(345,423)$572,514 Stock options exercised88,276 — 3,616 — — 3,616 Vesting of restricted stock units41,185 — — — — — Shares held for tax withholdings(14,373)— (2,848)— — (2,848)Issuance of common stock543 — 101 — — 101 Stock-based compensation expense— — 26,322 — — 26,322 Other comprehensive loss— — — (676)— (676)Net loss— — — — (10,005)(10,005)Balance at March 31, 202429,676,095 $30 $944,298 $124 $(355,428)$589,024 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

7

Inspire Medical Systems, Inc.

Consolidated Statements of Cash Flows (unaudited)

(in thousands)

 Three Months EndedMarch 31, 20252024Operating activities  Net income (loss)$2,992 $(10,005)Adjustments to reconcile net income (loss):  Depreciation and amortization3,044 839 Accretion of investment discount(1,209)(2,469)Stock-based compensation expense31,056 26,322 Provision (benefit) for estimated credit losses311 (1,392)Other non-cash expenses512 519 Changes in operating assets and liabilities:  Accounts receivable263 18,962